&nbsp;

PCC_4233_FN_CancerScreeningGuide.pdf

Nov 2021

Document

PCC_4233_FN_CancerScreeningGuide_FR.pdf

Nov 2021

Measuring Ontario’s Small Area Inequalities in Cancer (MOSAIC) Study

Document

MOSAIC_Placemat.pdf

Jan 2022

Document

mosaicPlacemat.jpg

Feb 2022

Regimen

PEMB(MNT)

Cancer Type:

Gynecologic,

Cervix

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Treated MSI-H/dMMR Advanced Endometrial Cancer

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

MFOLFOX6+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jan 2024

Regimen

PACL+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

PACLitaxel

Quick Link(s):

Regimen Monograph

May 2022

Regimen

PACL(W)+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

PACLitaxel